Altasciences has completed its bioanalytical lab expansion, which will be dedicated to ligand binding and cell-based assays. Altasciences has been growing its bioanalytical services and the added, state-of-the-art lab area ensures capacity for bioanalysis solutions for both preclinical and clinical clients.

The new, larger space, is fully equipped for cell-based neutralization and functional assays for biologics and vaccines, as well as additional capacity for cell lineage and functional immuno-phenotyping by flow cytometry to support preclinical and clinical studies.
 
“The extension of our bioanalytical laboratory ensures that we are equipped to continue providing the excellent bioanalytical services that Altasciences is known for. As demand for our services grows, we are committed to expanding our infrastructure and ensuring our usual, on-time delivery,” said Marie-Hélène Raigneau, Altasciences’ executive vice president, Research Services.